In recent years, pharmaceutical companies have leaned into omni-channel marketing strategies to improve the effectiveness and efficiency of their patient support programs, expand their reach, and adapt to ever-evolving consumer expectations. Omni-channel messaging focuses on…
Read more
Recently, the Biden-Harris Administration released a new fact sheet taking new steps to advance responsible AI research, development, and deployment. The goal of the fact sheet is to “protect individuals’ rights and safety and deliver…
Read more
Capturing consumer engagement and improving their experience with therapy must be top priorities for life sciences brands to drive improved medication behavior. Consumers are expecting more across every sector and healthcare is no exception. Patients…
Read more
Machine learning powers many of the services we regularly use, from personalized recommendations on Netflix and Spotify to voice assistants such as Siri or Alexa. In recent years, machine learning has gained momentum in healthcare…
Read more
Artificial intelligence (AI) has the power to dramatically transform healthcare—and in many ways, it already has. The use of AI in patient engagement programs is just one example of how it can encourage healthy behaviors,…
Read more
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of…
Read more
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of…
Read more
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
There are a lot of companies that claim they offer solutions that are powered by artificial intelligence (AI) and/or machine learning. But what exactly does that mean? AI and machine learning Artificial intelligence is a…
Read more
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck,…
Read more